AllSight
Companies · ESTA · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Company update · Aug 6, 2026

Revenue beat and guidance rose, but EPS missed as cash burn persists

ESTABLISHMENT LABS HOLDINGS INC. (ESTA) — what happened, in plain English, and what it means versus what the market expected.

The quarter cleared the main revenue hurdle but missed on EPS. Published consensus was roughly $65.7 million of revenue and a $0.31–$0.34 adjusted loss per share; revenue came in at $67.5 million, while GAAP loss per share was $0.39.

MetricQ2 2026Q2 2025Market expectation / comparison
Revenue$67.5M$51.3MConsensus ~$65.7M
Gross margin70.6%68.8%Improved year over year
Loss from operations$(4.3)M$(14.1)MNarrower loss
Net loss per share$(0.39)$(0.57)Consensus roughly $(0.31)–$(0.34)
Adjusted EBITDA$3.7M$(8.5)MSecond consecutive positive quarter
Net cash used in operations, six months$(20.9)M$(39.5)MCash burn improved, but remained substantial
Cash and equivalents$71.2M$75.6M at Dec. 31, 2025Down $4.4M year to date
Note payable$261.7M$247.5M at Dec. 31, 2025Debt increased

Underlying operating leverage was better than the headline loss suggests. Revenue grew 31.7% year over year, led in part by Motiva USA revenue rising to $24.7 million from $10.3 million, while gross margin expanded to 70.6% (Financial Highlights). Excluding $2.2 million of refinancing and restructuring charges, operating expenses rose only 2.0%, leaving the company with a much narrower operating loss of $4.3 million versus $14.1 million a year earlier (Financial Highlights; Reconciliation of EBITDA and Adjusted EBITDA).

The profitability milestone was real but not equivalent to cash profitability. Adjusted EBITDA reached $3.7 million versus negative $8.5 million last year, but the measure excludes stock compensation, foreign-currency effects, refinancing costs and restructuring charges (Reconciliation of EBITDA and Adjusted EBITDA). GAAP net loss was still $11.7 million, and six-month operating cash flow remained negative $20.9 million (Income Statement; Cash Flow statement).

The raised full-year revenue outlook is the clearest positive change versus the prior setup. Management said it was raising full-year revenue guidance, but this filing does not provide the new range, so the magnitude of the increase cannot be measured from the 8-K. The prior published range was $266.5 million–$268.5 million, versus consensus near $265.1 million, meaning the market already expected a relatively strong outlook before this release.

Net, this was modestly better than expected rather than a clean beat. Strong revenue, higher margins, positive adjusted EBITDA and raised guidance outweigh the EPS miss, but increased debt, $7.0 million of quarterly interest expense and continued cash consumption limit the quality of the improvement (Income Statement; Balance Sheet; Cash Flow statement).

Read the original 8-K on SEC EDGAR ↗
All ESTA filings, decoded →
Related companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies
Latest across the market
ACNAccenture earnings beat as Q4 revenue clears guidance, but FY27 growth stays measuredROPRoper Technologies adds NTT DATA CEO to board, but brings no operating changeIIPRIIPR loan increase funds Alewife buildout, but locks in 14% debtGLUEMonte Rosa GFORCE-1 results clear safety bar, but ASCVD Phase 2 moves to 2027SMASmartStop dividend holds at $1.60 annualized as October payout repeats patternHBNCHorizon Bancorp schedules Q3 earnings, offering no fresh business readBrowse all companies, decoded →
Open live on AllSight — the whole market, decoded →
AllSight turns SEC filings into plain-English, neutral reads and objective market context. We explain what happened and how it lands versus expectations — we do not give investment advice or predict prices. Decoded straight from the filing; check it against the source.
Analysis by AllSight · Editorial standards & method · Contact